首页|期刊导航|昆明医科大学学报|基于血清HIF-1 α与CysC构建急性左心衰并发呼吸衰竭患者28 d死亡风险预测模型

基于血清HIF-1 α与CysC构建急性左心衰并发呼吸衰竭患者28 d死亡风险预测模型OA

Construction of A 28-day Mortality Risk Prediction Model in Patients with Acute Left Heart Failure Complicated by Respiratory Failure Based on Serum HIF-1 α and CysC

中文摘要英文摘要

目的 探究急性左心衰(acute left heart failure,AHF)并发呼吸衰竭(respiratory failure,RF)患者血清缺氧诱导因子-1 α(hypoxia-inducible factor-1 alpha,HIF-1α)、胱抑素 C(Cystatin C,CysC)水平预测28 d 死亡风险的价值.方法 回顾性分析2022年1月至2024年12月株洲市中心医院收治的217例AHF伴RF患者的临床资料,根据患者出院28 d生存情况分组,其中死亡组(n=62)与存活组(n=155).比较两组患者一般资料及血清HIF-1α、CysC水平,分析AHF伴RF患者28 d死亡风险影响因素及血清HIF-1 α、CysC水平与28 d死亡风险的关系,采用受试者工作特征(receiver operating characteristic,ROC)曲线评价AHF伴RF患者HIF-1 α、CysC对28 d死亡风险的预测价值,并基于联合预测模型的进行风险分层与临床验证.结果 死亡组急性生理学与慢性健康状况评分Ⅱ(acute physiology and chronic health evaluation Ⅱ,APACHE Ⅱ)评分、序贯性脏器衰竭评价评分(sequential organ failure assessment,SOFA)评分、N 端 B 型脑钠肽前体(n-terminal pro-b-type natriuretic peptide,NT-proBNP)、HIF-1 α、CysC 均高于存活组(P<0.05);Logistic 回归显示 HIF-1 α、CysC 均为 AHF伴RF患者28 d死亡风险独立影响因素(P<0.05);限制性立方样条(restricted cubic spline,RCS)模型分析显示,调整其他变量后,血清HIF-1 α、CysC水平仍与AHF伴RF患者28 d死亡风险呈线性正相关(P<0.05),随血清HIF-1α、CysC升高,AHF伴RF患者的死亡风险逐渐增加;ROC曲线显示,APACHE Ⅱ评分、SOFA评分、NT-proBNP、HIF-1 α、CysC预测AHF伴RF患者28 d死亡风险的曲线下面积(area under curve,AUC)分别为0.737、0.711、0.768、0.748、0.753,各指标单独预测AUC比较差异无统计学意义(P>0.05);交互作用分析RERI=1.09、AP=0.253、SI=2.727,HIF-1 α与CysC两者同时升高时,对28 d死亡风险存在正向相加交互作用,即联合效应大于各自单独效应之和;血清HIF-1α、CysC联合预测AHF伴RF患者28 d死亡风险的 AUC 为 0.878,明显大于 APACHE Ⅱ 评分、SOFA 评分、NT-proBNP、HIF-1 α、CysC 单独预测的 AUC(P<0.05);绘制校准曲线显示,预测风险与实际观察风险在整个风险范围内具有良好的一致性(Hosmer-Lemeshow检验,x2=2.224,P=0.086);通过Bootstrap法(1 000次重抽样)进行内部验证,校正后模型的AUC为0.877,且校准曲线显示预测风险与实际风险一致性良好.DCA表明在0.2~0.8阈值概率范围内,使用该模型具有临床净获益,且时间验证集显示,模型具有较高的稳健性和较高的预测效能.基于联合预测模型将患者分为低、中、高风险组,三组28 d实际死亡率分别为4.17%、27.40%、54.17%(P<0.05).结论 AHF伴RF患者血清HIF-1α、CysC水平与28 d死亡风险密切相关,基于二者构建的联合预测模型具有良好的区分能力.

Objective To explore the predictive value of serum hypoxia-inducible factor-1alpha(HIF-1 α)and Cystatin C(CysC)levels for 28-day mortality risk in patients with acute left heart failure(AHF)complicated with respiratory failure(RF).Methods A retrospective analysis was conducted on clinical data from 217 AHF patients with concurrent RF admitted between January 2022 and December 2024.Patients were stratified based on 28-day survival status post-discharge into a mortality group(n=62)and a survival group(n=155).General demographic data and serum HIF-1 α and CysC levels were compared between the two groups.The influencing factors for 28-day mortality risk in AHF patients with RF and the relationship between serum HIF-1 α,CysC levels and 28-day mortality risk were analyzed.Receiver operating characteristic(ROC)curves were used to evaluate the predictive value of HIF-1 α and CysC for 28-day mortality risk in AHF with RF patients.Risk stratification and clinical validation were performed based on a combined predictive model.Results The mortality group demonstrated significantly higher Acute Physiology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ)scores(16.59±3.05 vs 13.72±2.47,t=7.214,P<0.001),Sequential Organ Failure Assessment(SOFA)scores(12.61±2.24 vs 11.89±2.15,t=2.202,P=0.029),N-terminal pro-B-type natriuretic peptide(NT-proBNP)(507.41±82.44 vs 329.49±70.55 pg/mL,t=15.975,P<0.001),HIF-1 α(30.14±4.58 vs 21.37±3.82 ng/L,t=14.410,P<0.001)and CysC(1.72±0.35 vs 1.30±0.28 mg/L,t=9.270,P<0.001)compared with the survival group.Logistic regression analysis showed that HIF-1 α(OR=1.315,95%CI:1.129-1.532)and CysC(OR=1.260,95%CI:1.105-1.437)were independent influencing factors for 28 day mortality risk in AHF with RF patients(P<0.05).Restricted cubic spline(RCS)model analysis demonstrated that after adjusting for other variables,serum HIF-1 α and CysC levels remained linearly and positively correlated with 28 day mortality risk in AHF with RF patients(P<0.05),with mortality risk progressively increasing as serum HIF-1 α and CysC levels elevated.ROC curve analysis revealed that the area under the curve(AUC)for predicting 28-day mortality risk were as follows:APACHE Ⅱ score 0.737(95%CI:0.673-0.794),SOFA score 0.711(0.646-0.771),NT-proBNP 0.768(0.706-0.822),HIF-1 α 0.748(0.684-0.804),and CysC 0.753(0.690-0.809),with no statistically significant differences in AUC between individual indicators(P>0.05).Interaction analysis revealed RERI=1.09,AP=0.253,and SI=2.727,indicating a positive additive interaction between HIF-1 α and CysC when both were simultaneously elevated,with the combined effect exceeding the sum of individual effects.The combined predictive AUC for serum HIF-1 α and CysC for 28-day mortality risk in AHF with RF patients was 0.878,significantly higher than the individual AUCs for APACHE Ⅱ score,SOFA score,NT-proBNP,HIF-1 α,and CysC(P<0.05).Calibration curves demonstrated good concordance between predicted and observed risk across the entire risk spectrum(Hosmer-Lemeshow test,x2=2.224,P=0.086).Internal validation via Bootstrap resampling(1000 iterations)yielded a corrected model AUC of 0.877(95%CI:0.828-0.927),with calibration curves demonstrating good agreement between predicted and actual risk.Decision curve analysis(DC A)indicated clinical net benefit within the threshold probability range of 0.2-0.8,and temporal validation demonstrated high model robustness and predictive performance.Patients stratified into low,intermediate,and high-risk groups based on the combined predictive model had actual 28-day mortality rates of 4.17%,27.40%,and 54.17%,respectively(P<0.05).Conclusion Serum HIF-1 α and CysC levels in AHF patients with concurrent RF are closely associated with 28-day mortality risk.A combined predictive model constructed from these two markers demonstrates excellent discriminative ability.

莫世芳;薛雅馨;宋嘉;陈安琪;王琳

株洲市中心医院心血管内科,湖南株洲 412007株洲市中心医院心血管内科,湖南株洲 412007株洲市中心医院心血管内科,湖南株洲 412007株洲市中心医院心血管内科,湖南株洲 412007株洲市中心医院呼吸与危重症医学科,湖南株洲 412007

医药卫生

急性左心衰呼吸衰竭28 d死亡风险缺氧诱导因子-1α胱抑素C

Acute left heart failureRespiratory failure28-day mortality riskHypoxia-inducible factor-1 αCystatin C

《昆明医科大学学报》 2026 (8)

70-80,11

湖南省自然科学基金(2024JJ7658)

10.12259/j.issn.2095-610X.S20260807

评论